Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

被引:1516
作者
Arrasate, M
Mitra, S
Schweitzer, ES
Segal, MR
Finkbeiner, S [1 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94141 USA
[4] Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94141 USA
[5] Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA
[6] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Neurol & Physiol, San Francisco, CA 94141 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature02998
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's disease is caused by an abnormal polyglutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron. Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial. To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage. Here we show, by survival analysis, that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and polyglutamine expansion; many neurons die without forming an inclusion body. Rather, the amount of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur. Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron. Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.
引用
收藏
页码:805 / 810
页数:6
相关论文
共 51 条
  • [1] A cell-based screen for drugs to treat Huntington's disease
    Aiken, CT
    Tobin, AJ
    Schweitzer, ES
    [J]. NEUROBIOLOGY OF DISEASE, 2004, 16 (03) : 546 - 555
  • [2] [Anonymous], 1994, Modeling Survival Data in Medical Research
  • [3] A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila
    Apostol, BL
    Kazantsev, A
    Raffioni, S
    Illes, K
    Pallos, J
    Bodai, L
    Slepko, N
    Bear, JE
    Gertler, FB
    Hersch, S
    Housman, DE
    Marsh, JL
    Thompson, LM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) : 5950 - 5955
  • [4] ARRASATE M, 2003, SOC NEUR ABSTR, V29
  • [5] Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
    Becher, MW
    Kotzuk, JA
    Sharp, AH
    Davies, SW
    Bates, GP
    Price, DL
    Ross, CA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 4 (06) : 387 - 397
  • [6] Impairment of the ubiquitin-proteasome system by protein aggregation
    Bence, NF
    Sampat, RM
    Kopito, RR
    [J]. SCIENCE, 2001, 292 (5521) : 1552 - 1555
  • [7] A monomeric red fluorescent protein
    Campbell, RE
    Tour, O
    Palmer, AE
    Steinbach, PA
    Baird, GS
    Zacharias, DA
    Tsien, RY
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 7877 - 7882
  • [8] Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity
    Chen, S
    Berthelier, V
    Yang, W
    Wetzel, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 311 (01) : 173 - 182
  • [9] A one-hit model of cell death in inherited neuronal degenerations
    Clarke, G
    Collins, RA
    Leavitt, BR
    Andrews, DF
    Hayden, MR
    Lumsden, CJ
    McInnes, RR
    [J]. NATURE, 2000, 406 (6792) : 195 - 199
  • [10] Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
    Cummings, CJ
    Reinstein, E
    Sun, YL
    Antalffy, B
    Jiang, YH
    Ciechanover, A
    Orr, HT
    Beaudet, AL
    Zoghbi, HY
    [J]. NEURON, 1999, 24 (04) : 879 - 892